Amendment to Sales Agreement between Nemaura Medical Inc. and Maxim Group LLC (March 4, 2020)
This amendment updates the sales agreement between Nemaura Medical Inc. and Maxim Group LLC, originally dated October 19, 2018. The main change is that the agreement will now continue indefinitely unless either party gives 10 days’ written notice to terminate it. All other terms remain unchanged. The amendment is binding on both parties and their successors, and can be signed in counterparts or by facsimile.
Exhibit 10.1
March 4, 2020
Mr. Dewan F.H. Chowdhury
Chief Executive Officer
Nemaura Medical Inc.
57 West 57th Street
New York, New York 10019
Re: Amendment to Sales Agreement, dated October 19, 2018
Dear Mr. Chowdhury:
Reference is made to that certain sales agreement, dated October 19, 2018, between Nemaura Medical Inc. (the “Company”) and Maxim Group LLC (“Maxim”) (the “Sales Agreement”). Notwithstanding anything in the Sales Agreement to the contrary, it is agreed that the Sales Agreement shall remain in full force and effect without a specific time-period term, provided that either the Company or Maxim may terminate the Sales Agreement upon 10 days’ prior written notice to the other party.
This Amendment may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original and shall be binding upon all parties, their successors and assigns, and all of which taken together shall constitute one and the same Amendment. A signature delivered by facsimile shall constitute an original.
This Amendment shall be governed pursuant to Section 12 of the Sales Agreement.
Very truly yours,
MAXIM GROUP LLC | |
| By: | /s/ Clifford A. Teller |
| Name: Clifford A. Teller Title: Executive Managing Director & Head of Investment Banking | |
ACCEPTED AND AGREED TO:
NEMAURA MEDICAL INC. | ||
| By: | /s/ Dewan F. H. Chowdgury | |
| Name: Dewan F. H. Chowdhury Title: Chief Executive Officer and Interim Chief Financial Officer | ||
